West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
302.20
-3.96 (-1.29%)
At close: Apr 27, 2026, 4:00 PM EDT
303.59
+1.39 (0.46%)
After-hours: Apr 27, 2026, 5:03 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Proprietary Products Revenue
2.62B2.49B2.33B
Proprietary Products Revenue Growth
5.27%6.75%-2.62%
West Vantage Products Revenue
597.60M582.00M558.70M
West Vantage Products Revenue Growth
2.68%4.17%1.12%
Revenue (Total)
3.22B3.07B2.89B
Revenue (Total) Growth
4.78%6.25%-1.92%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Proprietary Products Operating Profit
715.80M657.20M577.80M
Proprietary Products Operating Profit Growth
8.92%13.74%-18.63%
West Vantage Products Operating Profit
65.50M63.40M72.30M
West Vantage Products Operating Profit Growth
3.31%-12.31%0.28%
Operating Income (Other)
-126.30M-135.70M-80.20M
Operating Income (Total)
655.00M584.90M569.90M
Operating Income (Total) Growth
11.98%2.63%-15.70%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Organic Net Sales Growth
4.30%-1.50%
Updated Apr 23, 2026. Data Source: Fiscal.ai.